State Street’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-107
| Closed | -$3.1K | – | 4441 |
|
|
2023
Q3 | $3.1K | Hold |
107
| – | – | ﹤0.01% | 4547 |
|
|
2023
Q2 | $9.11K | Hold |
107
| – | – | ﹤0.01% | 4651 |
|
|
2023
Q1 | $44.9K | Hold |
107
| – | – | ﹤0.01% | 4527 |
|
|
2022
Q4 | $131K | Hold |
107
| – | – | ﹤0.01% | 4283 |
|
|
2022
Q3 | $85K | Hold |
107
| – | – | ﹤0.01% | 4515 |
|
|
2022
Q2 | $154K | Sell |
107
-232
| -68% | -$334K | ﹤0.01% | 4324 |
|
|
2022
Q1 | $708K | Sell |
339
-4
| -1% | -$8.35K | ﹤0.01% | 3916 |
|
|
2021
Q4 | $1.68M | Buy |
343
+4
| +1% | +$19.6K | ﹤0.01% | 3688 |
|
|
2021
Q3 | $2.13M | Buy |
339
+12
| +4% | +$75.3K | ﹤0.01% | 3594 |
|
|
2021
Q2 | $3.08M | Buy |
327
+123
| +60% | +$1.16M | ﹤0.01% | 3460 |
|
|
2021
Q1 | $1.78M | Buy |
204
+50
| +32% | +$435K | ﹤0.01% | 3481 |
|
|
2020
Q4 | $1.17M | Buy |
154
+4
| +3% | +$30.4K | ﹤0.01% | 3530 |
|
|
2020
Q3 | $983K | Buy |
150
+13
| +9% | +$85.2K | ﹤0.01% | 3444 |
|
|
2020
Q2 | $1.03M | Sell |
137
-1
| -0.7% | -$7.48K | ﹤0.01% | 3413 |
|
|
2020
Q1 | $987K | Buy |
138
+2
| +1% | +$14.3K | ﹤0.01% | 3309 |
|
|
2019
Q4 | $2.12M | Buy |
136
+17
| +14% | +$265K | ﹤0.01% | 3225 |
|
|
2019
Q3 | $1.13M | Buy |
119
+20
| +20% | +$189K | ﹤0.01% | 3371 |
|
|
2019
Q2 | $1.54M | Buy |
+99
| New | +$1.54M | ﹤0.01% | 3331 |
|